Mj. Simchen et al., ADJUSTMENT OF MAGNESIUM-SULFATE INFUSION RATE IN PATIENTS WITH PRETERM LABOR, American journal of obstetrics and gynecology, 179(4), 1998, pp. 994-998
OBJECTIVE: Our purpose was to investigate factors that might influence
serum magnesium levels during intravenous magnesium sulfate tocolytic
therapy. STUDY DESIGN: Thirty-three women receiving magnesium sulfate
for preterm labor participated in this prospective, observational stu
dy. Gestational ages were 24 to 34 weeks. Four groups of women were id
entified according to the maintenance magnesium infusion rate required
for arresting preterm labor after 5 g of therapy induction: 1.5, 2, 2
.5, and 3 g/h. Serum magnesium samples were drawn after a predefined p
eriod of at least 18 hours of arrested preterm labor, at a minimum of
every 6 hours. Variables examined included serum albumin; serum protei
n; serum ionized calcium; serum creatinine; creatinine clearance; 24-h
our urine output; maternal height, weight, body surface area; and body
mass index.RESULTS: By use of a multivariate stepwise regression mode
l we identified four variables that independently and significantly co
ntributed to the model: magnesium infusion rate (P<.001); total serum
protein level (P <.001); serum creatinine level (P=.009); and maternal
weight squared (P =.026). Seventy-two percent of the variance was acc
ounted for by use of these parameters. A predictive linear model, deve
loped to relate these factors, produced the following formula: Suggest
ed magnesium infusion rate = 0.89 x Serum magnesium concentration (mg/
dl) - 3.16 x Serum creatinine (mg/dL) - 0.66 x Serum total proteins (g
/dL) + 0.0001 x (materna[ weight)2 (kg) + 2.30. CONCLUSIONS: Serum cre
atinine, serum protein, and maternal weight can be used to adjust the
dose of magnesium sulfate in patients with premature labor to achieve
therapeutic serum levels of magnesium more rapidly and safely.